Updated Jul 16, 2026
Dixon Jonathan V. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Jonathan V. Dixon is identified in a February 18, 2026 SEC filing related to Bionano Genomics, Inc. Public biographical information beyond this filing is not provided in the context. Bionano Genomics is a biotechnology company known for developing optical genome mapping technology. No specific title, background, or career history for Dixon is confirmed in the provided SEC context.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 24 | $1.30 | $31 |
| 2026-02-18 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 6 | $1.10 | $7 |
Jonathan V. Dixon is identified in a February 18, 2026 SEC filing related to Bionano Genomics, Inc. Public biographical information beyond this filing is not provided in the context. Bionano Genomics is a biotechnology company known for developing optical genome mapping technology. No specific title, background, or career history for Dixon is confirmed in the provided SEC conte…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dixon Jonathan V. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.